Europe’s new “vaccine passport” programme, which recognises a few Covid-19 vaccines whose beneficiaries will be able to travel in and out of Europe, includes the AstraZeneca vaccine but not Covishield, which is produced in India.

Four vaccines—BioNTech-Pfizer, Moderna, AstraZeneca-Oxford, and Janssen Pharmaceutica NV—have been approved so far, according to the European Commission.

Poonawalla’s tweet came amid reports that travellers vaccinated with Covishield may not be eligible for the European Union’s “green pass,” a document that is meant for easy travel within and to the group of countries.

Many member-states of the European Union have begun issuing the digital vaccine passport to facilitate movement for work and tourism, according to The Hindu.

In June, India’s Covid-19 Working Group of the National Technical Advisory Group on Immunisation said that a single shot of the Covishield vaccine has an efficacy of 61% against the Delta variant of coronavirus, while two doses provide 65% protection. Cases of the Delta variant of Covid-19 have forced multiple countries to reimpose curbs.

This post first appeared on We welcome your comments at

📬 Sign up for the Daily Brief

Our free, fast, and fun briefing on the global economy, delivered every weekday morning.